Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. (Q34500828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

metastatic renal cell carcinoma

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Robert Motzer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

M H Voss

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

D A Bastos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C A Karlo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Ajeti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A A Hakimi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

J J Hsieh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A M Molina

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S Patil

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

publication date

23 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

663-668

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

cites work

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

2004 WHO classification of the renal tumors of the adults

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Contemporary approach to the classification of renal epithelial tumors.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

The Heidelberg classification of renal cell tumours.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT578

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT578

Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT578

NCCN guideline updates: colon and rectal cancers, version 1.2004.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4229900

Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24458473

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/ANNONC/MDT578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458473%20AND%20SRC:MED&resulttype=core&format=json